TMS: using the theta-burst protocol to explore mechanism of plasticity in individuals with Fragile X syndrome and autism.
Fragile X Syndrome (FXS), also known as Martin-Bell Syndrome, is a genetic abnormality found on the X chromosome. Individuals suffering from FXS display abnormalities in the expression of FMR1--a protein required for typical, healthy neural development. Recent data has suggested that the loss of this protein can cause the cortex to be hyperexcitable thereby affecting overall patterns of neural plasticity. In addition, Fragile X shows a strong comorbidity with autism: in fact, 30% of children with FXS are diagnosed with autism, and 2-5% of autistic children suffer from FXS. Transcranial Magnetic Stimulation (a non-invasive neurostimulatory and neuromodulatory technique that can transiently or lastingly modulate cortical excitability via the application of localized magnetic field pulses) represents a unique method of exploring plasticity and the manifestations of FXS within affected individuals. More specifically, Theta-Burst Stimulation (TBS), a specific stimulatory protocol shown to modulate cortical plasticity for a duration up to 30 minutes after stimulation cessation in healthy populations, has already proven an efficacious tool in the exploration of abnormal plasticity. Recent studies have shown the effects of TBS last considerably longer in individuals on the autistic spectrum--up to 90 minutes. This extended effect-duration suggests an underlying abnormality in the brain's natural plasticity state in autistic individuals, similar to the hyperexcitability induced by Fragile X Syndrome. In this experiment, utilizing single-pulse motor-evoked potentials (MEPs) as our benchmark, we will explore the effects of both intermittent and continuous TBS on cortical plasticity in individuals suffering from FXS and individuals on the Autistic Spectrum.
Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center.
Lindsay M
LM
Oberman
Jared C
JC
Horvath
Alvaro
A
Pascual-Leone
D001321:Autistic Disorder / Q000473:pathology / Q000503:physiopathology*; D002540:Cerebral Cortex / Q000473:pathology / Q000503:physiopathology; D019054:Evoked Potentials, Motor / Q000502:physiology; D005600:Fragile X Syndrome / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D009473:Neuronal Plasticity / Q000502:physiology*; D050781:Transcranial Magnetic Stimulation / Q000379:methods*
Am J Med Genet. 1999 Apr 2;83(4):268-79
10208160
Neuroscientist. 2009 Oct;15(5):549-67
19325170
Microsc Res Tech. 2002 May 1;57(3):168-73
12112453
Annu Rev Neurosci. 2002;25:315-38
12052912
Neuron. 2005 Jan 20;45(2):201-6
15664172
Exp Brain Res. 2007 Jul;180(4):583-93
17562028